Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
AI Sentiment
Highly Positive
8/10
as of 12-04-2025 3:44pm EST
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
| Founded: | 1984 | Country: | India |
| Employees: | N/A | City: | N/A |
| Market Cap: | 11.6B | IPO Year: | N/A |
| Target Price: | $16.90 | AVG Volume (30 days): | 923.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 0.79 | EPS Growth: | 9.95 |
| 52 Week Low/High: | $12.26 - $16.17 | Next Earning Date: | 01-22-2026 |
| Revenue: | $3,851,623,984 | Revenue Growth: | 14.10% |
| Revenue Growth (this year): | 6.16% | Revenue Growth (next year): | 2.57% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
RDY Breaking Stock News: Dive into RDY Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
AI Sentiment
Positive
7/10
See how RDY stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "RDY Dr. Reddy's Laboratories Ltd - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.